After Durnell: What Survives When Preemption Kills the Warning Claim

By LegalVault Pro Team · 2026-09-07

On June 25, 2026, the Supreme Court decided Monsanto v. Durnell, holding 7 to 2 that the Federal Insecticide, Fungicide, and Rodenticide Act preempts state-law failure-to-warn claims against the manufacturer of Roundup. Justice Brett Kavanaugh wrote for the majority. Justice Ketanji Brown Jackson dissented, joined by Justice Neil Gorsuch.

The reasoning is short and its consequences are not. FIFRA bars states from imposing labeling requirements that are, in the statute's language, in addition to or different from the federal requirements. The Environmental Protection Agency has assessed glyphosate and has not required a cancer warning on the label. A state-law claim that the manufacturer should have added such a warning therefore asks a jury to impose exactly the labeling obligation federal law withholds.

The plaintiff, John Durnell of St. Louis, used Roundup for decades maintaining public parks and developed non-Hodgkin lymphoma. A jury awarded him $1.25 million and the Missouri Court of Appeals upheld it. The Supreme Court reversed.

Reporting at the time of the decision put roughly 61,000 active cases in the pipeline nationally, out of something on the order of 180,000 filed over the preceding decade. A settlement hearing in the related proceedings has been reported for September 14, 2026. Those figures move; check current sources before relying on them.

What the Ruling Does and Does Not Say

This is a preemption holding about labeling. It is not a ruling that glyphosate is safe, and it is not a ruling that Monsanto did nothing wrong.

The Court did not weigh the epidemiology. It did not disturb the jury's factual findings about causation. It held that one particular theory of liability, the claim that the label should have said something the EPA has not required it to say, is unavailable as a matter of federal law.

That distinction matters enormously in practice, and it is where the next two years of this litigation will be fought. A judgment that a claim is preempted is not a judgment that a plaintiff was uninjured. It removes a route, not a fact.

Dissenting, Justice Jackson took the position that the majority read the preemption provision too broadly. Whatever one makes of that, the disagreement itself is a signal about the ruling's edges: a decision that the Court split 7 to 2 on, with a reasoned dissent about scope, is a decision whose boundaries will be litigated.

The Question Every File Now Has to Answer

Here is the practical problem for anyone holding these cases.

A large share of the pending inventory was pleaded around failure to warn, because that was the theory that had been winning. Those specific counts are now foreclosed. The question for each file is whether anything else was pleaded, whether anything else could be, and whether the facts of that particular plaintiff support it.

Theories that do not depend on what the label said are the obvious place to look. A design defect claim asks whether the product itself was unreasonably dangerous, not whether its warning was adequate. Claims sounding in negligent testing, or in affirmative misrepresentations made outside the label in marketing and public statements, are structurally different from a labeling claim. Whether any of them survives in a given jurisdiction, on a given record, against this preemption holding, is exactly the open question, and courts will answer it inconsistently for a while.

Nobody should take a general article's word for which theory survives in their forum. The point here is narrower and more urgent: that determination has to be made file by file, and it cannot be made from a case list. It requires looking at what each plaintiff actually pleaded, what the underlying exposure facts are, and what the governing state law permits.

For an inventory in the tens of thousands, that is not a legal question first. It is a records question.

What to Do About It

For firms holding affected inventory:

Where This Gets Won or Lost

Mass tort inventories fail in a specific and boring way. Not through bad lawyering on the merits, but because a change in the law arrives and nobody can determine quickly enough which of forty thousand files it actually affects.

The work of answering that is retrieval: what was pleaded, in which court, under which state's law, with what exposure facts, subject to which scheduling order. A firm that can run that query across its inventory in an afternoon is in a completely different position from one that has to open files one at a time to find out.

That is the ordinary infrastructure problem LegalVault Pro exists to address. Indexed matters, structured case data, and deadlines tied to the file rather than to somebody's memory. It does not decide whether a design defect theory survives preemption in Missouri. It tells you, today, which of your files are asking that question.

The Takeaway

Durnell did not end this litigation. It closed one door, in a body of cases large enough that simply finding out who was standing in that doorway is itself a major undertaking.

The firms that handle the next year well will not be the ones with the cleverest read of the preemption holding. They will be the ones that already know what is in their own files.

---

*This article describes a Supreme Court decision and its ongoing consequences. Case counts and settlement dates were accurate as reported and are expected to change; verify current figures against the linked sources. Nothing here is an opinion about which alternative theories survive preemption in any particular jurisdiction, which is a question for counsel on the specific file. Descriptions of law are general and are not legal advice. Details as of September 7, 2026.*

*Sources: NPR, June 25, 2026; CNBC, June 25, 2026; Oklahoma Farm Report, June 25, 2026; The Hill.*

← All articles